Anchiano Therapeutics (ANCN) Short Interest Ratio & Short Volume

Short interest is the volume of Anchiano Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 26th, traders have sold 65,200 shares of ANCN short. Learn More on Anchiano Therapeutics' current short interest.

Anchiano Therapeutics saw a decline in short interest during the month of February. As of February 26th, there was short interest totaling 65,200 shares, a decline of 65.7% from the previous total of 190,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Anchiano Therapeutics: Barinthus Biotherapeutics plc (0.11%), Xilio Therapeutics, Inc. (4.82%), LAVA Therapeutics (0.54%), Lantern Pharma Inc. (3.28%), ABVC BioPharma, Inc. (3.06%), Reviva Pharmaceuticals Holdings, Inc. (13.47%), NeuroSense Therapeutics Ltd. (1.76%), Rockwell Medical, Inc. (0.57%), Eagle Pharmaceuticals, Inc. (0.46%), Marinus Pharmaceuticals, Inc. (3.95%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.72 billion), Analog Devices, Inc. ($5.42 billion), Charter Communications, Inc. ($4.94 billion), Snap Inc. ($3.85 billion), Airbnb, Inc. ($2.46 billion), Warner Bros. Discovery, Inc. ($2.34 billion), Futu Holdings Limited Sponsored ADR ($2.31 billion), The Kroger Co. ($2.05 billion), Peloton Interactive, Inc. ($1.96 billion), and Palo Alto Networks, Inc. ($1.89 billion). View all of the most shorted stocks.

Short selling ANCN is an investing strategy that aims to generate trading profit from Anchiano Therapeutics as its price is falling. ANCN shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Anchiano Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ANCN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANCN, twice per month. The most recent reporting period available is February, 26 2021.